Proteolipoprotein Gene Analysis in 82 Patients with Sporadic Pelizaeus-Merzbacher Disease: Duplications, the Major Cause of the Disease, Originate More Frequently in Male Germ Cells, but Point Mutations Do Not
Open accessThe DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
Abstract
Pelizaeus-Merzbacher Disease (PMD) is an X-linked developmental defect of myelination affecting the central nervous system and segregating with the proteolipoprotein (PLP) locus. Investigating 82 strictly selected sporadic cases of PMD, we found PLP mutations in 77%; complete PLP-gene duplications were the most frequent abnormality (62%), whereas point mutations in coding or splice-site regions of the gene were involved less frequently (38%). We analyzed the maternal status of 56 cases to determine the origin of both types of PLP mutation, since this is relevant to genetic counseling. In the 22 point mutations, 68% of mothers were heterozygous for the mutation, a value identical to the two-thirds of carrier mothers that would be expected if there were an equal mutation rate in male and female germ cells. In sharp contrast, among the 34 duplicated cases, 91% of mothers were carriers, a value significantly (chi2=9. 20, P<.01) in favor of a male bias, with an estimation of the male/female mutation frequency (k) of 9.3. Moreover, we observed the occurrence of de novo mutations between parental and grandparental generations in 17 three-generation families, which allowed a direct estimation of the k value (k=11). Again, a significant male mutation imbalance was observed only for the duplications. The mechanism responsible for this strong male bias in the duplications may involve an unequal sister chromatid exchange, since two deletion events, responsible for mild clinical manifesta…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NA09545, from a male with XLR Pelizaeus-Merzbacher disease (PMD; OMIM #312080), characterized as a substitution disease mutation [PLP1 exon 5, c.767C>T, P215S (41)], was found to also feature PLP1 gene duplication [which is reported in 62% of sporadic PMD (42); Fig. 7B].”
From Carrier testing for severe childhood recessive diseases by next-generation sequencing (2011) · cites this paper as [42]
Citations
Cites
A comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,928 · cited 2×
“A PLP-intragenic microsatellite (Mimault et al. 1995) and the two nearest known flanking extragenic microsatellites, DXS1191 and DXS1106 (Dib et al. 1996), were used.”
BackgroundMethodDiscriminant Analysis and Statistical Pattern Recognition.
Hawkins, D. M., & McLachlan, G. J. (1993) · Journal of the American Statistical Association · doi:10.2307/2290355 · Cited by 2,633
Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A
Lakich, D., Kazazian, H. H., Antonarakis, S. E., & Gitschier, J. (1993) · Nature Genetics · doi:10.1038/ng1193-236 · Cited by 788 · cited 1×
“Here the proposed mechanism is a flipping of the tip of the X chromosome, which allows homologous pairing between copies of the A genes localized both within and outside of the factor VIII gene (Lakich et al. 1993).”
BackgroundThe rate of spontaneous mutation of a human gene
Haldane, J. B. S. (1935) · Journal of Genetics · doi:10.1007/bf02982403 · Cited by 513
The rate of spontaneous mutation of a human gene
Haldane, J. B. S. (2004) · Journal of Genetics · doi:10.1007/bf02717892 · Cited by 472
PENROSE, L. (1955) · The Lancet · doi:10.1016/s0140-6736(55)92305-9 · Cited by 345 · cited 1×
“For point mutations and small structural rearrangements, the active proliferation of spermatogonia, which after puberty divide every 16 days throughout life, may result in a large number of mutations that accumulate with age, to produce the paternal age effects (Penrose 1955).”
BackgroundDean, M., White, M. B., Amos, J., Gerrard, B., Stewart, C., Khaw, K.-T., & Leppert, M. (1990) · Cell · doi:10.1016/0092-8674(90)90196-l · Cited by 343 · cited 2×
“Detection of PLP Duplications in Patients with PMD A multiplex PCR-based test was performed to coamplify exon IV from the PLP gene (Gencic et al. 1989) and exon IV from the CFTR gene (Dean et al. 1990).”
BackgroundMethodExclusive paternal origin of new mutations in Apert syndrome
Moloney, D. M., Slaney, S. R., Oldridge, M., Wall, S. A., Sahlin, P., Stenman, G., & Wilkie, A. O. M. (1996) · Nature Genetics · doi:10.1038/ng0596-48 · Cited by 320 · cited 1×
“This is the case for point mutations in Apert syndrome, which involves a CpG dinucleotide and shows an extreme bias in favor of paternal origin, with evidence for increasing incidence with increasing paternal age (Moloney et al. 1996).”
BackgroundA rapid method for the purification of DNA from blood
Jeanpierre, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.22.9611 · Cited by 317 · cited 1×
“Genomic DNA was extracted by the guanidinium chloride technique, as described elsewhere (Jeanpierre 1987).”
MethodReiter, L. T., Murakami, T., Koeuth, T., Pentao, L., Muzny, D. M., Gibbs, R. A., & Lupski, J. R. (1996) · Nature Genetics · doi:10.1038/ng0396-288 · Cited by 296
Research works printed but not linked: 1
- Boespflug-Tanguy, 1997, Proteolipipid protein gene mutations in developmental defects of myelination, Med Genet Suppl, 9, 144
Cited by
Lee, J. A., Carvalho, C. M. B., & Lupski, J. R. (2007) · Cell · doi:10.1016/j.cell.2007.11.037 · Cited by 914
“As the nonrecurrent rearrangements causing PMD have been reported to occur during spermatogenesis (Inoue et al., 1999; Mimault et al., 1999), we suggest that the replicative error may have occurred during mitotic or meiotic DNA synthesis during the early stages (BlancoRodrı́guez, 2002a, 2002b), in…”
BackgroundCarrier testing for severe childhood recessive diseases by next-generation sequencing
Bell, C. J., Dinwiddie, D. L., Miller, N. A., Hateley, S. L., Ganusova, E. E., Mudge, J., Langley, R. J., Zhang, L., Lee, C. C., Schilkey, F. D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001756 · Cited by 706
Myelin Regeneration: A Recapitulation of Development?
Fancy, S. P. J., Chan, J. R., Baranzini, S. E., Franklin, R. J. M., & Rowitch, D. H. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113629 · Cited by 320
Inoue, K. (2005) · Neurogenetics · doi:10.1007/s10048-004-0207-y · Cited by 285
“In addition, the origin of the de novo duplication can often be traced to male ancestral chromosomes [104].”
BackgroundFragile X and X-Linked Intellectual Disability: Four Decades of Discovery
Lubs, H. A., Stevenson, R. E., & Schwartz, C. E. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.02.018 · Cited by 248
Li, W. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00354-4 · Cited by 223
Olig gene function in CNS development and disease
Ligon, K. L., Fancy, S. P. J., Franklin, R. J. M., & Rowitch, D. H. (2006) · Glia · doi:10.1002/glia.20273 · Cited by 223
“The archetype for this class is PMD, which in up to 77% of patients results from mutations or duplications of the PLP1 gene, encoding a major component of CNS myelin (Mimault et al., 1999).”
BackgroundCarvalho, C. M. B., Ramocki, M. B., Pehlivan, D., Franco, L. M., Gonzaga-Jauregui, C., Fang, P., McCall, A., Pivnick, E. K., Hines-Dowell, S., Seaver, L. H., et al. (2011) · Nature Genetics · doi:10.1038/ng.944 · Cited by 223
The genetic landscape of intellectual disability arising from chromosome X
Gécz, J., Shoubridge, C., & Corbett, M. (2009) · Trends in Genetics · doi:10.1016/j.tig.2009.05.002 · Cited by 207
Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis
Garbern, J. Y. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6182-8 · Cited by 189
Identification of disease genes by whole genome CGH arrays
Vissers, L. E. L. M., Veltman, J. A., van Kessel, A. G., & Brunner, H. G. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi268 · Cited by 167
Reid, E. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.2.81 · Cited by 166
Paternal Factors and Schizophrenia Risk: De Novo Mutations and Imprinting
Malaspina, D. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006882 · Cited by 162
Dhami, P., Coffey, A. J., Abbs, S. J., Vermeesch, J. R., Dumanski, J. P., Woodward, K. J., Andrews, R., Langford, C., & Vetrie, D. L. P. (2005) · The American Journal of Human Genetics · doi:10.1086/429588 · Cited by 147
“…its clinical relevance (table 1) (Atkin et al. 1988; Worton and Thompson 1988; Den Dunnen et al. 1989; Gillard et al. 1989; Nelis et al. 1996; Heim et al. 1997; Lemmink et al. 1997; Sistermans et al. 1998; Mimault et al. 1999; Plant et al. 1999; Rautenstrauss et al. 2000; Bruder et al. 2001).”
Butts, B. D., Houde, C., & Mehmet, H. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.70 · Cited by 146
Bauters, M., Esch, H. V., Friez, M. J., Boespflug‐Tanguy, O., Zenker, M., Vianna‐Morgante, A. M., Rosenberg, C., Ignatius, J., Raynaud, M., Hollanders, K., et al. (2008) · Genome Research · doi:10.1101/gr.075903.107 · Cited by 138
Self-citationWerner, H. B., Krämer‐Albers, E., Strenzke, N., Saher, G., Tenzer, S., Ohno‐Iwashita, Y., de Monasterio‐Schrader, P., Möbius, W., Moser, T., Griffiths, I. R., et al. (2013) · Glia · doi:10.1002/glia.22456 · Cited by 133
“In particular, mutations interfering with the YIYF motif in the SSD of human PLP cause the severe connatal form of Pelizaeus-Merzbacher disease (Mimault et al., 1999).”
BackgroundNeuron-Oligodendrocyte Interactions in the Structure and Integrity of Axons
Duncan, G. J., Simkins, T. J., & Emery, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.653101 · Cited by 125
X-linked intellectual disability update 2017
Neri, G., Schwartz, C. E., Lubs, H. A., & Stevenson, R. E. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38710 · Cited by 117
“More commonly, the condition is caused by duplications of the entire gene (Mimault et al., 1999; Regis et al., 2008).”
BackgroundThree or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease
Wolf, N. I. (2005) · Brain · doi:10.1093/brain/awh409 · Cited by 113
“…disease Nicole I. Wolf,1,6 Erik A. Sistermans,7 Maria Cundall,1 Grace M. Hobson,8,9 Angelique P. Davis-Williams,8 Rodger Palmer,3 Paula Stubbs,3 Sally Davies,5 Milda Endziniene,12 Yvonne Wu,10 Wui K. Chong,4 Sue Malcolm,1 Robert Surtees,2 James Y. Garbern11 and Karen J. Woodward1”
Koeppen, A. H., & Robitaille, Y. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.9.747 · Cited by 108
“In a systematic study of 82 patients with sporadic clinically diagnosed PMD, Mimault et al discovered PLP mutations in 63 (77%) of which 39 (62%) were duplications (55).”
BackgroundWoodward, K. J., Cundall, M., Sperle, K., Sistermans, E. A., Ross, M. T., Howell, G. R., Gribble, S. M., Burford, D. C., Carter, N. P., Hobson, D. L., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/498048 · Cited by 112
“2, and a mechanism of unequal sister-chromatid exchange during spermatogenesis has been proposed (Woodward et al. 1998; Inoue et al. 1999; Mimault et al. 1999).”
BackgroundThe molecular and cellular defects underlying Pelizaeus–Merzbacher disease
Woodward, K. J. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000677 · Cited by 100
The proteolipid protein gene and myelin disorders in man and animal models
Yool, D. A., Edgar, J. M., Montague, P., & Malcolm, S. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.987 · Cited by 102
De novo interstitial direct duplication of Xq21.1q25 associated with skewed X‐inactivation pattern
Tachdjian, G., Aboura, A., Benkhalifa, M., Creveaux, I., Foix-L'Hélias, L., Gadisseux, J., Boespflug‐Tanguy, O., Mohammed, M., & Labrune, P. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30359 · Cited by 82
Self-citationRole of genomic architecture in PLP1 duplication causing Pelizaeus-Merzbacher disease
Lee, J. A., Inoue, K., Cheung, S. W., Shaw, C. A., Stankiewicz, P., & Lupski, J. R. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl150 · Cited by 92
“PLP1 duplications resulting in PMD generally occur in tandem by an intra-chromosomal event in an ancestral male during gametogenesis (14,21,33).”
BackgroundBauer, J., Bradl, M., Klein, M., Leisser, M., Deckwerth, T. L., Wekerle, H., & Lassmann, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.1.12 · Cited by 71
“In human Pelizaeus-Merzbacher disease (PMD), mutations or elevated expression of the PLP gene causes hypomyelination or widespread demyelination resulting in severe neurological deficits (2).”
BackgroundNeurogenetics of Pelizaeus–Merzbacher disease
Osório, M. J., & Goldman, S. A. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00045-4 · Cited by 71
“The mechanism responsible for such male bias in duplications may involve unequal sister chromatid exchange, as proposed in other X linked disorders (Mimault et al., 1999).”
BackgroundPelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes
Inoue, K. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9636-7_13 · Cited by 72
Schweitzer, J., Becker, T., Schachner, M., Nave, K., & Werner, H. B. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.10.007 · Cited by 73
Glaser, R. L., & Jabs, E. W. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.3.re1 · Cited by 66
Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy
Shy, M. E., Hobson, G. M., Jain, M., Boespflug‐Tanguy, O., Garbern, J. Y., Sperle, K., Li, W., Gow, A., Rodriguez, D., Bertini, E., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10466 · Cited by 63
Self-citationTwo novel mutations confirm FGD1 is responsible for the Aarskog syndrome
Schwartz, C., Gillessen‐Kaesbach, G., May, M. M., Cappa, M., Gorski, J. L., Steindl, K., & Neri, G. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200553 · Cited by 58
Southwood, C. M., & Gow, A. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1054 · Cited by 61
“Gene duplication is the most common cause of PMD, accounting for approximately 50% of patients ( Mimault et al., 1999 ), and available data indicates that disease in these patients is a consequence of the overabundance of PLP gene products (Carango et al., 1995).”
BackgroundWarshawsky, I., Chernova, O. B., Hübner, C. A., Stindl, R., Henneke, M., Gal, A., & Natowicz, M. R. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.067967 · Cited by 53
“Discussion Our results suggest that MLPA has important advantages over quantitative PLP1 PCR assays that determine gene copy number from analysis of 1 or 2 PLP1 exons (6, 7, 10, 20, 21).”
BackgroundGenes involved in leukodystrophies: A glance at glial functions
Boespflug‐Tanguy, O., Labauge, P. M., Fogli, A., & Vaurs‐Barrière, C. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0034-x · Cited by 56
“The level of PLP overexpression seems to be correlated with the degree of disease severity, similar to transgenic mice overexpressing PLP [ 5 ].”
BackgroundSelf-citationAn update on the leukodsytrophies
Schiffmann, R., & Boespflug‐Tanguy, O. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200112000-00018 · Cited by 52
Self-citationSima, A. A. F., Pierson, C. R., Woltjer, R. L., Hobson, G. M., Golden, J. A., Kupsky, W. J., Schauer, G. M., Bird, T. D., Skoff, R. P., & Garbern, J. Y. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0562-8 · Cited by 52
“Point mutations affecting the PLP1 coding region provide a second mechanism leading to the development of PMD and are responsible for about 20% of cases [14, 25].”
Hudson, L. D. (2003) · Journal of Child Neurology · doi:10.1177/08830738030180090801 · Cited by 53
P elizaeus– M erzbacher disease: Cellular pathogenesis and pharmacologic therapy
Torii, T., Miyamoto, Y., Yamauchi, J., & Tanoue, A. (2014) · Pediatrics International · doi:10.1111/ped.12450 · Cited by 52
Inoue, K., Tanaka, H., Scaglia, F., Araki, A., Shaffer, L. G., & Lupski, J. R. (2001) · Annals of Neurology · doi:10.1002/ana.10036 · Cited by 45
“Compensation of Central Nervous System Myelin in Heterozygous Females Studies of more than 30 families with PLP duplication have shown that patients’ mothers are usually carriers for the duplication and present with no phenotype associated with PMD.10,11 Similarly, female carriers of point mutations that result in a s…”
BackgroundEpidemiological, clinical, and genetic landscapes of hypomyelinating leukodystrophies
Numata, Y., Gotoh, L., Iwaki, A., Kurosawa, K., Takanashi, J., Deguchi, K., Yamamoto, T., Osaka, H., & Inoue, K. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7263-5 · Cited by 48
“A similar proportional distribution of mutations has been estimated at the diagnostic laboratory level [8, 12, 18], but has not been determined by epidemiological studies.”
BackgroundOverexpression of KLC2 due to a homozygous deletion in the non-coding region causes SPOAN syndrome
Melo, U. S., Macedo‐Souza, L. I., Figueiredo, T., Muotri, A. R., Gleeson, J. G., Coux, G., Armas, P., Calcaterra, N. B., Kitajima, J. P., de Amorim, S. C., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv388 · Cited by 62
Grossi, S., Regis, S., Biancheri, R., Mort, M. E., Lualdi, S., Bertini, E., Uziel, G., Boespflug‐Tanguy, O., Simonati, A., Corsolini, F., et al. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-40 · Cited by 44
“[48], for discussion of this still contentious issue).”
BackgroundInfluentialSelf-citationThe Myelin Mutants as Models to Study Myelin Repair in the Leukodystrophies
Duncan, I. D., Kondo, Y., & Zhang, S. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0080-y · Cited by 53
“The majority (>60%) of boys with PMD have a duplication of the plp1 gene [14, 15], but no naturally occurring duplications exist in animals.”
BackgroundSeventeen novelPLP1mutations in patients with Pelizaeus-Merzbacher disease
Hübner, C. A., Orth, U., Senning, Å., Steglich, C., Kohlschütter, A., Korinthenberg, R., & Gal, A. (2005) · Human Mutation · doi:10.1002/humu.9314 · Cited by 42
“Point Mutations Point mutations and small rearrangements of PLP1 account for approximately 15 to 20% of PMD alleles (Sistermans et al., 1998; Garbern et al., 1999; Mimault et al., 1999), and are distributed throughout the gene.”
BackgroundMethodResultInfluentialRobust quantification of the SMN gene copy number by real-time TaqMan PCR
Gómez-Curet, I., Robinson, K. G., Funanage, V. L., Crawford, T. O., Scavina, M. T., & Wang, W. (2007) · Neurogenetics · doi:10.1007/s10048-007-0093-1 · Cited by 44
“The primers, probes, and nonextending oligonucleotides for SMN and cystic fibrosis transmembrane regulator (CFTR) gene amplifications were designed based on those of previous studies [20, 22, 25] with minor modifications (Table 1).”
MethodYoshimatsu, S., Okahara, J., Sone, T., Takeda, Y., Nakamura, M., Sasaki, E., Kishi, N., Shiozawa, S., & Okano, H. (2019) · Scientific Reports · doi:10.1038/s41598-018-37990-w · Cited by 39
Potential primary roles of glial cells in the mechanisms of psychiatric disorders
Yamamuro, K., Kimoto, S., Rosen, K. M., Kishimoto, T., & Makinodan, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00154 · Cited by 43
“Proteolipid protein 1, a major protein in CNSmyelin (Inoue et al., 1996; Mimault et al., 1999), is regarded as an “adhesive strut” that binds adjacent lamellae of the compacted myelin membrane (Boison et al., 1995).”
BackgroundMarteyn, A., Sarrazin, N., Yan, J., Bachelin, C., Deboux, C., Santin, M. D., Gressens, P., Zujovic, V., & Baron-Van Evercooren, A. (2016) · Stem Cells · doi:10.1002/stem.2263 · Cited by 38
Woodward, K. J., Kirtland, K. A., Dlouhy, S. R., Raskind, W. H., Bird, T. D., Malcolm, S., & Abeliovich, D. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200480 · Cited by 38
Separate Proteolipid Protein/DM20 Enhancers Serve Different Lineages and Stages of Development
Tuason, M. C., Rastikerdar, A., Kuhlmann, T., Goujet‐Zalc, C., Zalc, B., Dib, S., Friedman, H. C., & Peterson, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4579-07.2008 · Cited by 35
“Separate Proteolipid Protein/DM20 Enhancers Serve”
InfluentialShimojima, K. Y., Inoue, T., Hoshino, A., Kakiuchi, S., Watanabe, Y., Sasaki, M., Nishimura, A., Takeshita-Yanagisawa, A., Tajima, G., Ozawa, H., et al. (2009) · Brain and Development · doi:10.1016/j.braindev.2009.02.011 · Cited by 36
Novel pathologic findings in patients with Pelizaeus-Merzbacher disease
Laukka, J. J., Kamholz, J. A., Bessert, D. A., & Skoff, R. P. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.05.028 · Cited by 34
“The most common form of PMD, representing 60-70% respectively, has been shown to be due to X-chromosomal duplications that include the PLP 1 gene [26, 34, 50].”
BackgroundWhere, when and how much: regulation of myelin proteolipid protein gene expression
Dobretsova, A., & Wight, P. A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3309-z · Cited by 40
Ruest, T., Holmes, W. M., Barrie, J. A., Griffiths, I. R., Anderson, T. J., Dewar, D., & Edgar, J. M. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1700 · Cited by 34
Prenatal interphase FISH diagnosis of PLP1 duplication associated with Pelizaeus–Merzbacher disease
Inoue, K., Kanai, M., Tanabe, Y., Kubota, T., Kashork, C. D., Wakui, K., Fukushima, Y., Lupski, J. R., & Shaffer, L. G. (2001) · Prenatal Diagnosis · doi:10.1002/pd.186 · Cited by 33
“A large genomic duplication in Xq22 that contains the entire PLP1 is responsible for the majority of patients with PMD (Inoue et al., 1999; Mimault et al., 1999).”
BackgroundTSPY variants in six loci on the human Y chromosome
Dechend, F., Williams, G., Skawran, B., Schubert, S., Krawczak, M., Tyler‐Smith, C., & Schmidtke, J. (2000) · Cytogenetic and Genome Research · doi:10.1159/000056821 · Cited by 31
“PLP1 is located on the X chromosome and represents a candidate gene for Pelizaeus-Merzbacher disease (PMD).”
BackgroundKhalaf, G., Mattern, C., Bégou, M., Boespflug‐Tanguy, O., Massaad, C., & Massaad-Massade, L. (2022) · Biomedicines · doi:10.3390/biomedicines10071709 · Cited by 38
Self-citationDeletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability
Wang, E., Dimova, N., Sperle, K., Huang, Z., Lock, L. F., McCulloch, M. C., Edgar, J. M., Hobson, G. M., & Cambi, F. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.09.001 · Cited by 37
“(Cailloux et al., 2000; Garbern, 2002; Mimault et al., 1999; Shy et al., 2003).”
Emerging cellular themes in leukodystrophies
Nowacki, J. C., Fields, A. M., & Fu, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.902261 · Cited by 35
“The jimpy mouse model expresses a truncated defective copy of PLP1 and shares similar cellular and neurological phenotypes with severe PMD patients.”
BackgroundInfluentialSumida, K., Inoue, K., Takanashi, J., Sasaki, M., Watanabe, K., Suzuki, M., Kurahashi, H., Omata, T., Tanaka, M., Yokochi, K., et al. (2016) · Brain and Development · doi:10.1016/j.braindev.2015.12.007 · Cited by 32
Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease
Gruenenfelder, F. I., McLaughlin, M., Griffiths, I. R., Garbern, J. Y., Thomson, G., Kuzman, P., Barrie, J. A., McCulloch, M. C., Penderis, J., Stassart, R. M., et al. (2020) · Brain · doi:10.1093/brain/awaa080 · Cited by 27
“Duplications of the PLP1 locus represent the most common cause of PMD (Sistermans et al. , 1998; Mimault et al. , 1999); however, variation in the size and break points of the duplicated region on the X chromosome and in the site of recombination likely contribute to the range of severity, even…”
BackgroundCombes, P., Bonnet‐Dupeyron, M., Gauthier‐Barichard, F., Schiffmann, R., Bertini, E., Rodriguez, D., Armour, J. A. L., Boespflug‐Tanguy, O., & Vaurs‐Barrière, C. (2006) · Neurogenetics · doi:10.1007/s10048-005-0021-1 · Cited by 24
“PLP1 duplication diagnosis in HL patients is mostly performed with PCR-based techniques amplifying only one or two exons [3, 4 , 9] and FISH techniques [9, 11].”
BackgroundMethodInfluentialSelf-citationBonnet‐Dupeyron, M., Combes, P., Santander, P., Cailloux, F., Boespflug‐Tanguy, O., & Vaurs‐Barrière, C. (2008) · Human Mutation · doi:10.1002/humu.20758 · Cited by 24
“In all patients, PLP1 abnormalities were screened as previously described: 1) by gene quantification using a semiquantitative PCR of exons 2 and 4 [Mimault et al., 1999], as well as by MAPH using 13 probes all along the PLP1 gene [Combes et al.”
BackgroundMethodInfluentialSelf-citationPrenatal diagnosis of Pelizaeus‐Merzbacher disease
Garbern, J. Y., & Hobson, G. M. (2002) · Prenatal Diagnosis · doi:10.1002/pd.465 · Cited by 22
Neurodegenerative Disorder Related to AIMP1/p43 Mutation Is Not a PMLD
Boespflug‐Tanguy, O., Aubourg, P. R., Dorboz, I., Bégou, M., Giraud, G., Sarret, C., & Vaurs‐Barrière, C. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.12.015 · Cited by 21
Self-citationLugtenberg, D., de Brouwer, A. P. M., Oudakker, A. R., Pfundt, R., Hamel, B. C. J., van Bokhoven, H., & Bongers, E. M. H. F. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32742 · Cited by 25
“2, Table II) [Vejerslev et al., 1985;Thode et al., 1988;Muscatelli et al., 1992; Yokoyama et al., 1992; Apacik et al., 1996; Shapira et al., 1997; Hou, 2004].”
Hudson, L. D., Garbern, J. Y., & Kamholz, J. A. (2004) · Elsevier eBooks · doi:10.1016/b978-012439510-7/50090-5 · Cited by 20
Regis, S., Grossi, S., Lualdi, S., Biancheri, R., & Filocamo, M. (2005) · Neurogenetics · doi:10.1007/s10048-005-0214-7 · Cited by 19
Modeling the natural history of Pelizaeus–Merzbacher disease
Mayer, J. A., Griffiths, I. R., Goldman, J. E., Smith, C. M., Cooksey, E., Radcliff, A. B., & Duncan, I. D. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.023 · Cited by 18
“The majority of boys have duplications of the gene, with the number of extra copies of the gene dictating the severity of the disease (Harding et al., 1995; Inoue et al., 1999; Mimault et al., 1999; Wolf et al., 2005).”
MicroRNA expression in mouse oligodendrocytes and regulation of proteolipid protein gene expression
Wang, E., & Cambi, F. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23055 · Cited by 19
“More than 60% of Pelizaeus-Merzbacher disease (PMD) cases are due to duplication of the PLP gene causing overexpression of the PLP/DM20 proteins (Mimault et al., 1999; Hobson et al., 2002; Inoue, 2005; Garbern, 2007; Karim et al., 2007; Boespflug-Tanguy et al., 2008), so the miR-20a characterized…”
BackgroundCNS myelination and PLP gene dosage
Woodward, K. J., & Malcolm, S. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.3.263 · Cited by 17
Hobson, G. M., & Kamholz, J. A. (2013) · Cited by 17
Woodward, K. J., Cundall, M., Palmer, R. W., Surtees, R. A. H., Winter, R. M., & Malcolm, S. (2002) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10103 · Cited by 17
“Various lines of evidence have led to the conclusion that most PLP1 gene duplications arise by unequal crossing over between sister chromatids (intrachromosomal) in male meiosis leading to a tandem head to tail rearrangement within Xq22 [Woodward et al., 1998; Inoue et al., 1999; Mimault et al., 1999].”
BackgroundInfluentialVaurs‐Barrière, C., Bonnet-Dupeyron, M. N., Combes, P., Gauthier‐Barichard, F., Reveles, X. T., Schiffmann, R., Bertini, E., Rodriguez, D., Vago, P., Armour, J. A. L., et al. (2005) · Annals of Human Genetics · doi:10.1111/j.1529-8817.2005.00208.x · Cited by 17
“Discrepancies using FISH analysis have also been reported for 8p22-p23 duplications in Kabuki syndrome (Milunsky & Huang, 2003; Miyake et al. 2004; Engelen et al. 2005; Hoffman et al. 2005; Sanlaville et al. 2005; Turner et al. 74 Annals of Human Genetics (2005) 70,66–77 C© University College…”
MethodSelf-citationLaššuthová, P., Zaliova, M. K., Inoue, K., Haberlová, J., Sixtová, K., Sakmaryová, I., Paděrová, K., Mazanec, R., Zámečník, J., Šišková, D., et al. (2013) · Journal of Child Neurology · doi:10.1177/0883073813492387 · Cited by 16
“mutations (missense, nonsense and splicing) and other small mutations (insertions and deletions), which constitute together about 15-20% of PLP1 mutations.(1,8) The PLP1 mutations act through distinct pathogenic mechanisms—loss of function, gain of function, and dosage effect.”
BackgroundMayer, J. A., Larsen, E. C., Kondo, Y., & Duncan, I. D. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.07.007 · Cited by 18
Prenatal diagnosis ofPLP1 copy number by array comparative genomic hybridization
Lee, J. A., Cheung, S. W., Ward, P. A., Inoue, K., & Lupski, J. R. (2005) · Prenatal Diagnosis · doi:10.1002/pd.1308 · Cited by 16
“2 (Inoue et al., 1996; Sistermans et al., 1998; Woodward et al., 1998; Inoue et al., 1999; Mimault et al., 1999), and less commonly from PLP1 deletions (Raskind et al.”
BackgroundDiffusion tensor imaging of patients with proteolipid protein 1 gene mutations
Laukka, J. J., Makki, M., Lafleur, T., Stanley, J. A., Kamholz, J. A., & Garbern, J. Y. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23458 · Cited by 13
“…disease; CNS; myelin; DT-MRI Pelizaeus-Merzbacher disease (PMD) is an X-linked disorder of the central nervous system (CNS) caused by a wide variety of mutations affecting proteolipid protein 1 (PLP1), the major protein in CNS myelin (Raskind et al., 1991; Inoue et al., 1996; Mimault et al., 1999).”
BackgroundStruys, T., Krage, T., Vandenabeele, F., Raab, W. H.-M., & Lambrichts, I. (2004) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2004.11.007 · Cited by 13
A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene
Lee, E. S., Moon, H. K., Park, Y. H., Garbern, J. Y., & Hobson, G. M. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.05.015 · Cited by 14
Inborn errors of brain myelin formation
Boespflug‐Tanguy, O. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00027-7 · Cited by 13
Self-citationMild Pelizaeus-Merzbacher disease caused by a point mutation affecting correct splicing of PLP1 mRNA
Hübner, C., Senning, Å., Orth, U., Zerres, K., Urbach, H., Gal, A., & Rudnik‐Schöneborn, S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.042 · Cited by 12
Xu, Y., Wang, H., Xiao, B., Wei, W., Liu, Y., Ye, H., Ying, X., Chen, Y., Liu, X., Ji, X., et al. (2017) · Gene · doi:10.1016/j.gene.2017.12.037 · Cited by 12
PLP1 gene analysis in 88 patients with leukodystrophy
Martínez‐Montero, P., Muñoz-Calero, M., Vallespín, E., Campistol, J., Martorell, L., Ruiz‐Falcó, M., Santana, A., Pons, R., Dinopoulos, A., Sierra, C., et al. (2013) · Clinical Genetics · doi:10.1111/cge.12103 · Cited by 11
Is involvement of inflammation underestimated in Pelizaeus–Merzbacher disease?
Marteyn, A., & Evercooren, A. B. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23931 · Cited by 12
“Second, the classic form, which accounts for 62% of all cases (Inoue et al., 1996; Sistermans et al., 1998; Mimault et al., 1999), results from a complete PLP1 gene duplication.”
BackgroundFunctional disomy for Xq22‐q23 in a girl with complex rearrangements of chromosomes 3 and X
Ida, T., Miharu, N., Hayashitani, M., Shimokawa, O., Harada, N., Samura, O., Kubota, T., Niikawa, N., & Matsumoto, N. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20096 · Cited by 11
“Duplications of PLP1 account for 50–75% [Hodes et al., 1993], and point mutations for 15–20% of PMD patients [Sistermans et al., 1998; Mimault et al., 1999].”
BackgroundMikešová, E., Baránková, L., Sakmaryová, I., Tatarková, I., & Seeman, P. (2006) · Genetic Testing · doi:10.1089/gte.2006.10.215 · Cited by 10
“1998; Mimault et al .”
Duan, R., Ji, H., Yan, H., Wang, J., Zhang, Y., Zhang, Q., Li, D., Cao, B., Wu, Y., Wu, Y., et al. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02267-z · Cited by 9
Pelizaeus‐Merzbacher syndrome: Neurocognitive function in a family with carrier manifestations
Marble, M., Voeller, K. S., May, M. M., Stevenson, R. E., Schwartz, C. E., & Simensen, R. J. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31804 · Cited by 9
“Point mutations have been found in 10–25% of the cases, while the majority of the patients have duplications of the gene [Hodes and Dlouhy, 1996; Sistermans et al., 1998; Woodward et al., 1998; Mimault et al., 1999; Inoue et al., 2002].”
BackgroundChapter 17 Hereditary spastic paraparesis
McDermott, C. J., & Shaw, P. J. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)80020-0 · Cited by 9
Transplantation of Oligodendrocyte Progenitor Cells in Animal Models of Leukodystrophies
Kondo, Y., & Duncan, I. D. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-931-4_12 · Cited by 8
Mutation analysis of the M6b gene in patients with Pelizaeus–Merzbacher‐like syndrome
Henneke, M., Wehner, L., Hennies, H. C., Preuss, N., & Gärtner, J. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30068 · Cited by 8
Effects of Intron 1 Sequences on Human PLP1 Expression: Implications for PLP1 -Related Disorders
Wight, P. A. (2017) · ASN NEURO · doi:10.1177/1759091417720583 · Cited by 7
“In humans, both segmental deletion (Raskind et al., 1991; Inoue et al., 2002) and duplication (Sistermans et al., 1998; Inoue et al., 1999; Mimault et al., 1999; Hodes et al., 2000) or higher copy number (Wolf et al., 2005) of the chromosomal region containing the PLP1 gene can lead to the…”
BackgroundSolassol, J., Rahil, H., Sapin, V., Lemery, D. J., Dastugue, B., Boespflug‐Tanguy, O., & Creveaux, I. (2003) · Prenatal Diagnosis · doi:10.1002/pd.579 · Cited by 7
“2) as a reference gene (Mimault et al., 1999).”
Self-citationOptical genome mapping in an atypical Pelizaeus-Merzbacher prenatal challenge
Rogač, M., Kovanda, A., Lovrečić, L., & Peterlin, B. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1173426 · Cited by 7
A Novel PLP1 Mutation Further Expands the Clinical Heterogeneity at the Locus
Hand, C. K., Bernard, G., Dubé, M., Shevell, M. I., & Rouleau, G. A. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013263 · Cited by 7
Pelizaeus-Merzbacher Disease and X-linked Spastic Paraplegia Type 2
(2005) · Springer eBooks · doi:10.1007/3-540-27660-2_34 · Cited by 6
Inherited white matter disorders: Hypomyelination (myelin disorders)
Perrier, S., Gauquelin, L., & Bernard, G. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-99209-1.00014-4 · Cited by 5
Metadata
- Authors
- Mimault, C., Giraud, G., Courtois, V., Cailloux, F., Boire, J. Y., Dastugue, B., & Boespflug-Tanguy, O.
- Affiliations
- Inserm (FR)
- ORCID
- Courtois, Virginie
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 1999-08
- Volume
- 65
- Issue
- 2
- Pages
- 360-369
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1377935
- OpenAlex
- W2020789006
- Cited by
- 133
- References
- 49
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 6 · 2013: 5 · 2012: 4
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 5101 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Association Européenne contre les Leucodystrophies (PL951405)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- Pelizaeus-Merzbacher disease, point mutations, de novo mutations, carrier mother, unequal sister chromatid exchange, genetic counseling, sporadic cases
- MeSH terms
- Diffuse Cerebral Sclerosis of Schilder, DNA Mutational Analysis, DNA-Binding Proteins, Family Health, Female, Gene Frequency, Germ Cells, Haplotypes, Heterozygote, Humans, Male, Molecular Sequence Data, Mothers, Polymorphism, Genetic, Sex Characteristics, Transcription Factors, Reproducibility of Results, Polymerase Chain Reaction, Point Mutation, Gene Dosage, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Duplication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.